Operating costs (Tables)
|
12 Months Ended |
Dec. 31, 2019 |
|---|
| Operating costs |
|
| Summary of research and development expenditure |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31,
|
|
|
|
2019
|
|
2018
|
|
2017
|
|
|
|
|
(Euro, in thousands)
|
|
Personnel costs
|
|
€
|
(124,260)
|
|
€
|
(81,352)
|
|
€
|
(59,950)
|
|
Subcontracting
|
|
|
(249,926)
|
|
|
(197,644)
|
|
|
(123,054)
|
|
Disposables and lab fees and premises costs
|
|
|
(23,880)
|
|
|
(25,525)
|
|
|
(22,277)
|
|
Depreciation
|
|
|
(10,874)
|
|
|
(5,655)
|
|
|
(3,679)
|
|
Other operating expenses
|
|
|
(18,380)
|
|
|
(12,699)
|
|
|
(9,542)
|
|
Total R&D expenses
|
|
€
|
(427,320)
|
|
€
|
(322,875)
|
|
€
|
(218,502)
|
|
| Summary of research and development expenditure by program |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31,
|
|
|
|
2019
|
|
2018
|
|
2017
|
|
|
|
|
(Euro, in thousands)
|
|
Filgotinib program
|
|
€
|
(100,032)
|
|
€
|
(66,138)
|
|
€
|
(53,212)
|
|
IPF program on GLPG1690
|
|
|
(75,951)
|
|
|
(72,718)
|
|
|
(16,190)
|
|
OA program on GLPG1972
|
|
|
(19,958)
|
|
|
(15,751)
|
|
|
(7,317)
|
|
Toledo program
|
|
|
(47,204)
|
|
|
(20,967)
|
|
|
(8,075)
|
|
CF program
|
|
|
(3,897)
|
|
|
(30,137)
|
|
|
(46,192)
|
|
AtD program on MOR106
|
|
|
(24,051)
|
|
|
(14,999)
|
|
|
(8,404)
|
|
Other programs
|
|
|
(156,227)
|
|
|
(102,165)
|
|
|
(79,113)
|
|
Total R&D expenses
|
|
€
|
(427,320)
|
|
€
|
(322,875)
|
|
€
|
(218,502)
|
|
| Summary of general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31,
|
|
|
|
2019
|
|
2018
|
|
2017
|
|
|
|
|
(Euro, in thousands)
|
|
Personnel costs and directors fees
|
|
€
|
(51,906)
|
|
€
|
(25,495)
|
|
€
|
(17,756)
|
|
Depreciation
|
|
|
(1,513)
|
|
|
(513)
|
|
|
(606)
|
|
Legal and professional fees
|
|
|
(11,775)
|
|
|
(4,284)
|
|
|
(2,427)
|
|
Other operating expenses
|
|
|
(8,506)
|
|
|
(5,339)
|
|
|
(3,626)
|
|
Total general and administrative expenses
|
|
€
|
(73,701)
|
|
€
|
(35,631)
|
|
€
|
(24,415)
|
|
| Summary of sales and marketing expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31,
|
|
|
|
2019
|
|
2018
|
|
2017
|
|
|
|
|
(Euro, in thousands)
|
|
Personnel costs
|
|
€
|
(7,558)
|
|
€
|
(2,282)
|
|
€
|
(2,156)
|
|
Depreciation
|
|
|
(61)
|
|
|
—
|
|
|
—
|
|
External outsourcing costs
|
|
|
(15,722)
|
|
|
(1,284)
|
|
|
(42)
|
|
Other operating expenses
|
|
|
(1,236)
|
|
|
(580)
|
|
|
(604)
|
|
Total sales and marketing expenses
|
|
€
|
(24,577)
|
|
€
|
(4,146)
|
|
€
|
(2,803)
|
|